Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Systemic Valacyclovir (Valtrex) to Arrest Further Progression of Severe Periodontitis

NCT05712343 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05712343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Systemic Valacyclovir (Valtrex) to Arrest Further Progression of Severe Periodontitis
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Unknown status
Start date
May 25, 2023
Completion date
March 1, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe periodontitis